GE HealthCare Technologies Inc.

GEHC · Nasdaq · ·

Comparar

83,05 US$+1,5 %cierre 13 nov

Cifras hasta el 30 de septiembre de 2026, del 10-Q presentado el 28 de octubre de 2026

1W: +0,8 %
1M: +18,1 %

Acciones de GE HealthCare Technologies Inc. (GEHC) — ¿es un buen negocio? — InspectStocks

GE HealthCare Technologies Inc.

GEHC · Nasdaq · ·

Comparar

83,05 US$+1,5 %cierre 13 nov

Cifras hasta el 30 de septiembre de 2026, del 10-Q presentado el 28 de octubre de 2026

1W: +0,8 %
1M: +18,1 %

Just reported

Q3 2026 results

From GE HealthCare Technologies's results release of 28 de octubre de 2026; its quarterly report has since been filed.

Revenue
Actual
5,51B US$
+7,2 % y/y
+4,1 % q/q
Guided
—
No guide given
EPS, GAAP
Actual
1,36 US$
+39 % y/y
+9,7 % q/q
Guided
—
No guide given
Operating income, GAAP
Actual
805M US$
+23 % y/y
+8,9 % q/q
Guided
—
No guide given

Company outlook

Full year 2026

EPS, adjusted4,95 US$ – 5,05 US$Raised +2,0 %

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes GE HealthCare Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The theme it is part of

Selección
Medical devices
Por InspectStocks · 20 companies
Surgical robots, implants, heart devices, glucose monitors and other medical equipment.
Precio, 1 año
+6,2 %
Ingresos, 1 año
+7,2 %
+14
A 8B 7C 3D 2

Highest-graded in Medical Devices

Graded A or B and worth $2B or more: A first, then the largest.

All 132 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

Cómo gana dinero

Imaging, ultrasound, and procedure-guidance equipment and services (Advanced Imaging Solutions)71 %
Contrast agents and radiopharmaceuticals (Pharmaceutical Diagnostics)15 %
Patient monitoring and life-support equipment, supplies, and services (Patient Care Solutions)14 %

Los porcentajes de ingresos son estimaciones para nine months ended September 30, 2026, no cifras de un informe oficial.

Compite con

SEMHFSiemens Healthineers
PHGPhilips
D
Tamaño
29,2B US$
Margen
0,0 %
UIHCFUnited Imaging Healthcare
MRBAYMindray
CAJCanon
BAYRYBayer

Qué vende6

Computed tomography scanners
Scanners use X-rays to create cross-sectional and three-dimensional images that can help clinicians find problems such as tumors, blocked blood vessels, or fractures.
Magnetic resonance scanners
Scanners use magnetic fields to create detailed images of internal body structures, including the brain, heart, and muscles.
Ultrasound systems
Systems use sound waves to create images for diagnosis and monitoring, including during pregnancy, heart examinations, and procedures.

Mostrar 3 más

X-ray systems
Fixed, portable, and moving-image X-ray equipment helps clinicians examine bones, lungs, and other parts of the body.
Patient monitors and electrocardiogram devices
Devices measure and display signs such as heart rhythm, blood pressure, and oxygen levels so care teams can track patients.
Contrast agents and radiopharmaceuticals
These medicines are given before or during scans to make certain tissues or biological activity easier to see in images.

Quién se lo compra4

Hospitals and health systems buy imaging, ultrasound, patient monitoring, and life-support equipment, often alongside maintenance or service agreements.
Imaging centers and other clinics buy scanners, ultrasound systems, supplies, and related service.
Public, academic, and government healthcare institutions buy equipment, diagnostic agents, and services through direct sales teams, distributors, or public purchasing processes.
Pharmaceutical companies and researchers buy or use radiopharmaceuticals and imaging services for research and clinical trials.

En qué se apoya y qué podría romperlo

De qué depende el negocio

1Manufacturing depends on reliable supplies of components and raw materials, including memory chips, as well as functioning supplier, factory, and transport networks.
2Sales depend partly on hospitals' and public healthcare systems' budgets, purchasing decisions, and access to government funding or reimbursement.
3Medical devices, pharmaceutical products, and digital services require regulatory approvals and ongoing compliance in the countries where they are sold or used.
4Some products and services rely on third-party suppliers, distributors, technology providers, and collaboration or licensing partners.

Qué podría salir mal

1Tariffs and higher costs or shortages for components, raw materials, and freight can raise production costs or delay deliveries; the company said tariffs and geopolitical disruption affected its costs and supply chain in 2026.
2Chinese local competitors and volume-based purchasing policies have affected orders and revenue in China and could put pressure on future demand or prices there.
3Patient Care Solutions faced operational fulfillment problems in 2026, including shortages of critical components that prevented some orders from being filled; the business was also under strategic review.

Estados financieros completos →

Sobre GE HealthCare Technologies Inc.

GE HealthCare makes scanners that create images of the body using X-rays, magnetic fields, or sound waves, along with equipment used to guide procedures and monitor patients. It also sells contrast agents and radioactive imaging drugs that help clinicians interpret scans, and provides equipment maintenance, software, and cloud services. Its software includes tools that use artificial intelligence (AI) to help with image analysis and clinical workflows.

Sede: Chicago, Illinois, United States
Fundada en: 1892
Empleados: approximately 54,000 (2025-12-31, high)
Cotiza en: Nasdaq
Cierre del ejercicio: December 31

Construido a partir de los propios informes de GE HealthCare Technologies Inc. ante la Comisión de Bolsa y Valores de EE. UU. (SEC). Las cifras son las declaradas, con el historial por acción reexpresado a la base de acciones de hoy. Esto describe un negocio: no es asesoramiento de inversión ni una recomendación de compra o venta.

Just reported